Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $553,054 (100.0% shares, 0.0% debt)

Holdings (9)

— ABIOMED INC 37.6%

Value ($000) $207,785 Shares 1,450,000 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 21.9%

Value ($000) $121,230 Shares 4,592,047 Est. Cost $31.50 Unrealized —

AXGN AXOGEN INC 14.7%

Value ($000) $81,424 Shares 4,861,111 Est. Cost $4.01 Unrealized +236.5%

— CORIUM 12.6%

Value ($000) $69,776 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENTELLUS MEDICAL INC 9.7%

Value ($000) $53,516 Shares 3,231,656 Est. Cost $21.90 Unrealized —

— ENDOLOGIX INC 2.1%

Value ($000) $11,699 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 1.1%

Value ($000) $6,156 Shares 1,170,370 Est. Cost $2.95 Unrealized +90.1%

ACUR ACURA PHARMACEUTICALS INC 0.2%

Value ($000) $1,096 Shares 1,956,397 Est. Cost $3.40 Unrealized -84.4%

— CATALYST 0.1%

Value ($000) $372 Shares 78,622 Est. Cost $4.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	1,450,000	$207,785	37.6%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$121,230	21.9%	$31.50	—	COM	761330109
AXGN	AXOGEN INC	4,861,111	$81,424	14.7%	$4.01	+236.5%	COM	05463X106
—	CORIUM	9,353,304	$69,776	12.6%	$7.77	—	COM	21887L107
—	ENTELLUS MEDICAL INC	3,231,656	$53,516	9.7%	$21.90	—	COM	29363K105
—	ENDOLOGIX INC	1,257,468	$11,699	2.1%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$6,156	1.1%	$2.95	+90.1%	COM	58468P206
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$1,096	0.2%	$3.40	-84.4%	COM	00509L802
—	CATALYST	78,622	$372	0.1%	$4.80	—	COM	14888D109